Delivery Order SPE2DB20D3101-SPE2DB25FRAL1
Award Date
1/30/25
Potential Completion Date
1/31/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price of $3,393.60 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product, with a period of performance through January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN38X, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,849.66 firm fixed-price delivery order is for the supply of 4566903724 CATHFLO ACTIVASE 2 MG VIALS, a critical medical commodity. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $2,670.36 firm fixed-price delivery order is for the provision of 4564750980 CATHFLO ACTIVASE 2 MG VIALS. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,070.76 delivery order contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical medical product, to support military healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,922.92 Firm Fixed Price Delivery Order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the...
This federal contract award, SPE2DX15D3201|SPE2DX24F3A2E, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $6,908.42 firm-fixed price delivery order is for 4564814571 CATHFLO ACTIVASE 2 MG VIALS, with a completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which...
This federal contract award, with the ID SPE2DX15D2101|SPE2DX24F52MY, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,275.78 firm fixed-price delivery order is for the supply of 4564823313 CATHFLO ACTIVASE 2 MG VIALS, with a completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, SPE2DB22D1106|SPE2DB25FDJP3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,212.70 firm fixed-price delivery order is for the supply of 4566293159 CATHFLO ACTIVASE 2 MG VIALS. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. There is no set-aside designation specified. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $2,246.16 firm fixed-price contract is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a medical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,861.74 firm fixed-price delivery order is for the supply of ACTIVASE 50 MG VIALS, a critical medication. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...